vs

Side-by-side financial comparison of Gevo, Inc. (GEVO) and HARTE HANKS INC (HHS). Click either name above to swap in a different company.

Gevo, Inc. is the larger business by last-quarter revenue ($45.3M vs $39.9M, roughly 1.1× HARTE HANKS INC). HARTE HANKS INC runs the higher net margin — 5.5% vs -13.2%, a 18.8% gap on every dollar of revenue. On growth, Gevo, Inc. posted the faster year-over-year revenue change (695.6% vs -15.4%). Gevo, Inc. produced more free cash flow last quarter ($8.7M vs $-686.0K). Over the past eight quarters, Gevo, Inc.'s revenue compounded faster (237.1% CAGR vs -6.4%).

Gevo, Inc. is an American renewable chemicals and advanced biofuels company headquartered in unincorporated Douglas County, Colorado, in the Denver-Aurora metropolitan area. Gevo operates in the sustainability sector, pursuing a business model based on the concept of the "circular economy". The company develops bio-based alternatives to petroleum-based products using a combination of biotechnology and classical chemistry. Gevo uses the GREET model from Argonne National Laboratory as a basis f...

Harte Hanks is a global marketing services company headquartered in Boston, Massachusetts. Harte Hanks services include analytics, strategy, marketing technology, creative services, digital marketing, customer care, direct mail, logistics, and fulfillment.

GEVO vs HHS — Head-to-Head

Bigger by revenue
GEVO
GEVO
1.1× larger
GEVO
$45.3M
$39.9M
HHS
Growing faster (revenue YoY)
GEVO
GEVO
+711.0% gap
GEVO
695.6%
-15.4%
HHS
Higher net margin
HHS
HHS
18.8% more per $
HHS
5.5%
-13.2%
GEVO
More free cash flow
GEVO
GEVO
$9.4M more FCF
GEVO
$8.7M
$-686.0K
HHS
Faster 2-yr revenue CAGR
GEVO
GEVO
Annualised
GEVO
237.1%
-6.4%
HHS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
GEVO
GEVO
HHS
HHS
Revenue
$45.3M
$39.9M
Net Profit
$-6.0M
$2.2M
Gross Margin
Operating Margin
-4.8%
-0.3%
Net Margin
-13.2%
5.5%
Revenue YoY
695.6%
-15.4%
Net Profit YoY
65.9%
EPS (diluted)
$-0.03
$0.30

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GEVO
GEVO
HHS
HHS
Q4 25
$45.3M
$39.9M
Q3 25
$42.7M
$39.5M
Q2 25
$43.4M
$38.6M
Q1 25
$29.1M
$41.6M
Q4 24
$5.7M
$47.1M
Q3 24
$2.0M
$47.6M
Q2 24
$5.3M
$45.0M
Q1 24
$4.0M
$45.4M
Net Profit
GEVO
GEVO
HHS
HHS
Q4 25
$-6.0M
$2.2M
Q3 25
$-8.0M
$-2.3M
Q2 25
$2.1M
$-335.0K
Q1 25
$-21.7M
$-392.0K
Q4 24
$-17.6M
Q3 24
$-21.2M
$142.0K
Q2 24
$-21.0M
$-27.8M
Q1 24
$-18.9M
$-171.0K
Operating Margin
GEVO
GEVO
HHS
HHS
Q4 25
-4.8%
-0.3%
Q3 25
-8.6%
1.3%
Q2 25
13.4%
0.1%
Q1 25
-69.2%
-0.1%
Q4 24
-344.7%
-3.3%
Q3 24
-1221.8%
4.0%
Q2 24
-456.8%
3.0%
Q1 24
-580.0%
0.8%
Net Margin
GEVO
GEVO
HHS
HHS
Q4 25
-13.2%
5.5%
Q3 25
-18.6%
-5.8%
Q2 25
4.9%
-0.9%
Q1 25
-74.6%
-0.9%
Q4 24
-308.9%
Q3 24
-1076.6%
0.3%
Q2 24
-399.3%
-61.8%
Q1 24
-473.1%
-0.4%
EPS (diluted)
GEVO
GEVO
HHS
HHS
Q4 25
$-0.03
$0.30
Q3 25
$-0.03
$-0.31
Q2 25
$0.01
$-0.05
Q1 25
$-0.09
$-0.05
Q4 24
$-0.08
$-0.31
Q3 24
$-0.09
$0.02
Q2 24
$-0.09
$-3.84
Q1 24
$-0.08
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GEVO
GEVO
HHS
HHS
Cash + ST InvestmentsLiquidity on hand
$81.2M
$5.6M
Total DebtLower is stronger
$164.8M
Stockholders' EquityBook value
$466.3M
$20.5M
Total Assets
$718.9M
$91.8M
Debt / EquityLower = less leverage
0.35×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GEVO
GEVO
HHS
HHS
Q4 25
$81.2M
$5.6M
Q3 25
$72.6M
$6.5M
Q2 25
$57.3M
$4.8M
Q1 25
$65.3M
$9.0M
Q4 24
$189.4M
$9.8M
Q3 24
$223.2M
$5.9M
Q2 24
$245.7M
$11.0M
Q1 24
$270.6M
$11.5M
Total Debt
GEVO
GEVO
HHS
HHS
Q4 25
$164.8M
Q3 25
$164.5M
Q2 25
$167.5M
Q1 25
$167.0M
Q4 24
$67.1M
Q3 24
$67.0M
Q2 24
$66.8M
Q1 24
$68.3M
Stockholders' Equity
GEVO
GEVO
HHS
HHS
Q4 25
$466.3M
$20.5M
Q3 25
$468.9M
$19.9M
Q2 25
$474.1M
$22.2M
Q1 25
$469.8M
$21.4M
Q4 24
$489.5M
$21.7M
Q3 24
$504.7M
$21.0M
Q2 24
$522.7M
$20.6M
Q1 24
$541.9M
$20.0M
Total Assets
GEVO
GEVO
HHS
HHS
Q4 25
$718.9M
$91.8M
Q3 25
$685.2M
$92.7M
Q2 25
$702.1M
$95.0M
Q1 25
$677.8M
$100.6M
Q4 24
$583.9M
$101.8M
Q3 24
$583.9M
$108.1M
Q2 24
$617.9M
$109.7M
Q1 24
$633.6M
$113.4M
Debt / Equity
GEVO
GEVO
HHS
HHS
Q4 25
0.35×
Q3 25
0.35×
Q2 25
0.35×
Q1 25
0.36×
Q4 24
0.14×
Q3 24
0.13×
Q2 24
0.13×
Q1 24
0.13×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GEVO
GEVO
HHS
HHS
Operating Cash FlowLast quarter
$20.0M
$737.0K
Free Cash FlowOCF − Capex
$8.7M
$-686.0K
FCF MarginFCF / Revenue
19.3%
-1.7%
Capex IntensityCapex / Revenue
24.7%
3.6%
Cash ConversionOCF / Net Profit
0.33×
TTM Free Cash FlowTrailing 4 quarters
$-43.5M
$-4.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GEVO
GEVO
HHS
HHS
Q4 25
$20.0M
$737.0K
Q3 25
$-6.8M
$3.2M
Q2 25
$-2.5M
$-4.8M
Q1 25
$-24.0M
$-818.0K
Q4 24
$-18.8M
$4.0M
Q3 24
$-11.0M
$-2.9M
Q2 24
$-11.4M
$1.6M
Q1 24
$-16.1M
$-5.7M
Free Cash Flow
GEVO
GEVO
HHS
HHS
Q4 25
$8.7M
$-686.0K
Q3 25
$-14.6M
$2.2M
Q2 25
$-7.8M
$-5.1M
Q1 25
$-29.9M
$-923.0K
Q4 24
$-33.5M
$3.4M
Q3 24
$-20.8M
$-4.9M
Q2 24
$-20.6M
$926.0K
Q1 24
$-33.6M
$-6.2M
FCF Margin
GEVO
GEVO
HHS
HHS
Q4 25
19.3%
-1.7%
Q3 25
-34.2%
5.5%
Q2 25
-17.9%
-13.1%
Q1 25
-102.7%
-2.2%
Q4 24
-587.2%
7.3%
Q3 24
-1057.0%
-10.2%
Q2 24
-392.4%
2.1%
Q1 24
-841.9%
-13.7%
Capex Intensity
GEVO
GEVO
HHS
HHS
Q4 25
24.7%
3.6%
Q3 25
18.3%
2.5%
Q2 25
12.1%
0.6%
Q1 25
20.0%
0.3%
Q4 24
256.6%
1.3%
Q3 24
496.2%
4.0%
Q2 24
174.8%
1.5%
Q1 24
438.9%
1.2%
Cash Conversion
GEVO
GEVO
HHS
HHS
Q4 25
0.33×
Q3 25
Q2 25
-1.18×
Q1 25
Q4 24
Q3 24
-20.76×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GEVO
GEVO

Segment breakdown not available.

HHS
HHS

Fulfillment And Logistics Services$17.3M43%
Customer Care$13.7M34%
Other$8.9M22%

Related Comparisons